Director, Strategic Marketing, Biologics
九月 06, 2013
The revision places limits on what drug manufacturers can print or otherwise display on the top surface of cap overseals and ferrules (aluminum shells) used to secure injectable drug vials. No printing or information displayed on caps or seals will be grandfathered by the revised chapter. So although your printing or labeling may have been approved in the past, you need to make sure that it is in compliance with the new details of the standard.
Act now to ensure that your supply chain is not interrupted. Contact your West Account Services Representative or Account Manager to request a new item and specification as needed.
For more information about the USP Ch <1> Labeling revisions click here.